Pharma
When Justin Liu and Scott Morris walked away from their roles at Rockset, an AI infrastructure startup acquired by OpenAI in June 2023, they had no prior experience in healthcare. But they had an idea, one that was shaped by a year of rigorous research, obtaining medical coding credentials, and interviewing over 100 healthcare professionals. That idea became Charta Health, an AI-powered platform aimed at automating patient chart reviews, and it has already turned heads with an $8.1 million seed round led by Bain Capital Ventures.
Liu and Morris didn't enter healthcare lightly. They understood that healthcare technology is often constrained by bureaucratic inefficiencies, outdated infrastructure, and deep-rooted resistance to change. But they also saw an opportunity. Manual chart reviews, a tedious yet essential process in patient care and billing, were ripe for automation.
From Cold Emails to Profitability in Record Time
Charta Health's inception was anything but traditional. The company’s first major success came not from networking with venture capitalists or industry veterans but from cold outreach. Within just 60 days of sending emails to potential clients, Charta secured $500,000 in revenue. This traction was so rapid that it pushed the startup into profitability before it even launched from stealth in June 2024.
